Lymphadenopathy diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Lymphadenopathy}} {{CMG}};{{AE}}{{ADS}} ==Overview== ==Diagnostic Criteria== ==References== {{reflist|2}} Category:primary care Category:Inflammations ..." |
No edit summary |
||
| (19 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lymphadenopathy}} | {{Lymphadenopathy}} | ||
{{CMG}};{{AE}}{{ADS}} | {{CMG}};{{AE}}{{ADS}}{{DYM}} [[Ogechukwu Hannah Nnabude, MD]] | ||
==Overview== | ==Overview== | ||
Diagnostic criteria could help to differentiate lymphadenopathy causes. Diagnostic criteria for malignant and benign [[lymphadenopathy]] vary based on size, location, risk factors, and symptoms. | |||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
Diagnostic criteria could help to differentiate lymphadenopathy causes.<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |year=2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid9803196">{{cite journal |vauthors=Ferrer R |title=Lymphadenopathy: differential diagnosis and evaluation |journal=Am Fam Physician |volume=58 |issue=6 |pages=1313–20 |date=October 1998 |pmid=9803196 |doi= |url=}}</ref> | |||
====Malignant Lymphadenopathy==== | |||
:*Node > 2 cm | |||
:*Node that is draining, hard, or fixed to underlying tissue | |||
:*Atypical location (e.g. [[supraclavicular]] node) | |||
:*Risk factors (e.g. [[HIV AIDS|HIV]] or [[TB]]) | |||
:*[[Fever]] and/or weight loss | |||
:*[[Splenomegaly]] | |||
====Benign Lymphadenopathy==== | |||
:*Node < 1 cm | |||
:*Node that is mobile, soft-or tender, and is not fixed to underlying tissue | |||
:*Common location (e.g. [[supraclavicular]] node) | |||
:*No associated risk factors | |||
:*Palpable and painful enlargement | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Physical examination]] | [[Category:Physical examination]] | ||
Latest revision as of 05:18, 9 December 2021
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria |
|
Risk calculators and risk factors for Lymphadenopathy diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]Delband Yekta Moazami, M.D.[3] Ogechukwu Hannah Nnabude, MD
Overview
Diagnostic criteria could help to differentiate lymphadenopathy causes. Diagnostic criteria for malignant and benign lymphadenopathy vary based on size, location, risk factors, and symptoms.
Diagnostic Criteria
Diagnostic criteria could help to differentiate lymphadenopathy causes.[1][2]
Malignant Lymphadenopathy
- Node > 2 cm
- Node that is draining, hard, or fixed to underlying tissue
- Atypical location (e.g. supraclavicular node)
- Risk factors (e.g. HIV or TB)
- Fever and/or weight loss
- Splenomegaly
Benign Lymphadenopathy
- Node < 1 cm
- Node that is mobile, soft-or tender, and is not fixed to underlying tissue
- Common location (e.g. supraclavicular node)
- No associated risk factors
- Palpable and painful enlargement
References
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Ferrer R (October 1998). "Lymphadenopathy: differential diagnosis and evaluation". Am Fam Physician. 58 (6): 1313–20. PMID 9803196.